Edesa Biotech earnings were -$6.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest EDSA earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$1.6M, up 68.1% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, EDSA reported annual earnings of -$6.2M, with -26.3% growth. The next EDSA earnings date is May 8, 2025.
On EDSA's earnings call on Invalid Date, Edesa Biotech (NASDAQ: EDSA) reported Q4 2024 earnings per share (EPS) of -$0.48, up 11.11% year over year. Total EDSA earnings for the quarter were -$1.62 million. In the same quarter last year, Edesa Biotech's earnings per share (EPS) was -$0.54.
The next EDSA earnings date is Invalid Date. Add EDSA to your watchlist to be reminded of Edesa Biotech's next earnings date.
What was EDSA's earnings growth in the past year?
As of Edesa Biotech's earnings date in Invalid Date, Edesa Biotech's earnings has grown year over year. EDSA earnings in the past year totalled -$6.11 million.
Is Edesa Biotech profitable or losing money?
As of the last Edesa Biotech earnings report, Edesa Biotech is currently losing money. Edesa Biotech's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$6.11 million, a 20.85% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.